Optimal extent of lymph node dissection for siewert type II esophagogastric junction carcinoma

Annals of Surgery

Volumn 254, Issue 2, 2011, Pages 274-280

  Yamashita, Hiroharu ^a   Katai, Hitoshi ^a   Morita, Shinji ^a   Saka, Makoto ^a   Taniguchi, Hirokazu ^a   Fukagawa, Takeo ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CARDIA CARCINOMA; CELIAC ARTERY; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HEPATIC ARTERY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIEWERT TYPE 2 ESOPHAGOGASTRIC JUNCTION CARCINOMA; SPLEEN ARTERY; SURVIVAL RATE; SURVIVAL TIME; TOTAL STOMACH RESECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SPLENECTOMY; STOMACH NEOPLASMS;

EID: 79961085825     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182263911     Document Type: Article

References (25)

1. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004;31(4):450-464. (Pubitemid 39070265)
2. Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 2008;23(11):1662-1665.
3. Sobin LH, Gospodarowicz MK, Wittekind CH. TNM Classification of Malignant Tumours. 7th ed. Wiley-Blackwell; 2009.
4. Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 2007;246(1):1-8. (Pubitemid 47012198)
5. Leers JM, DeMeester SR, Chan N, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 2009;138(3):594-602.
6. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1, 002 consecutive patients. Ann Surg 2000;232(3):353-361.
7. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7(8):644-651. (Pubitemid 44123569)
8. Aikou T, Shimazu H. Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 1989;19(3):290-295. (Pubitemid 19208489)
9. Japanese G, Cancer A. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998;1(1):10-24.
10. Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 1995;82(3):346-351.
11. Kunisaki C, Shimada H, Nomura M, et al. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach. Surgery 2005;137(2):165-171. (Pubitemid 40174423)
12. Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 1996;9:173-182. (Pubitemid 26264246)
13. Fang WL, Wu CW, Chen JH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 2009;16(12):3237-3244.
14. Maruyama K, Kaminishi M, Hayashi K, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer 2006;9(2):51-66. (Pubitemid 43890701)
15. Papachristou DN, Fortner JG. Adenocarcinomaofthe gastric cardia. Thechoice of gastrectomy. Ann Surg 1980;192(1):58-64. (Pubitemid 10083261)
16. Johansson J, Djerf P, Oberg S, et al. Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J Surg 2008;32(6):1013-1020.
17. Jakl RJ, Miholic J, Koller R, et al. Prognostic factors in adenocarcinoma of the cardia. Am J Surg 1995;169(3):316-319.
18. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123(2):127-130. (Pubitemid 28110072)
19. Katai H, Sano T, Fukagawa T, et al. Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 2003;90(7):850-853. (Pubitemid 36886388)
20. Katai H, Morita S, Saka M, et al. Long-term outcome after proximal gastrectomy with jejunal interposition for suspected early cancer in the upper third of the stomach. Br J Surg 2010;97(4):558-562.
21. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347(21):1662-1669. (Pubitemid 35340784)
22. Wayman J, Bennett MK, Raimes SA, et al. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 2002;86(8):1223-1229.
23. Katai H, Maruyama K, Sasako M, et al. Mode of recurrence after gastric cancer surgery. Dig Surg 1994;11:99-103.
24. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26(7):1086-1092.
25. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355(1):11-20.